If you need an accessible version of this item please contact JSTOR User Support

Corporate Social Responsibility (CSR): Models and Theories in Stakeholder Dialogue

Linda O'Riordan and Jenny Fairbrass
Journal of Business Ethics
Vol. 83, No. 4 (Dec., 2008), pp. 745-758
Published by: Springer
Stable URL: http://www.jstor.org/stable/25482410
Page Count: 14
  • Download PDF
  • Cite this Item

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If you need an accessible version of this item please contact JSTOR User Support
Corporate Social Responsibility (CSR): Models and Theories in Stakeholder Dialogue
Preview not available

Abstract

The pharmaceutical sector, an industry already facing stiff challenges in the form of intensified competition and strategic consolidation, has increasingly become subject to a range of pressures. Crucially, in common with other large-scale businesses, pharmaceutical firms find themselves 'invited' to respond positively to the corporate 'social' responsibility (CSR) expectations of their stakeholders. Consequently, individual managers will almost certainly be obliged to engage in some form of stakeholder dialogue and this, in turn, means that they will have to make difficult choices about which practices to adopt. This real-world management predicament runs parallel to an academic interest in CSR stakeholder dialogue theory and models. Accordingly, the approach of this paper is to focus primarily on the academic debate surrounding stakeholder dialogue, by reviewing past attempts to research and theorise the subject, by identifying gaps and weaknesses in the literature, and by proposing a new analytical model. The central aim of the proposed new model is to offer a unified, structured, systematic, and comprehensive approach to CSR decision making whilst simultaneously providing a practical framework for CSR executives who face the challenge of responding in an effective manner to stakeholders. The model outlined here is currently being employed to conduct international comparative empirical research into stakeholder dialogue practices amongst UK and German pharmaceutical firms. In the longer term the intention is to use the model to undertake international comparative research encompassing a broader range of countries and industries.

Page Thumbnails

  • Thumbnail: Page 
[745]
    [745]
  • Thumbnail: Page 
746
    746
  • Thumbnail: Page 
747
    747
  • Thumbnail: Page 
748
    748
  • Thumbnail: Page 
749
    749
  • Thumbnail: Page 
750
    750
  • Thumbnail: Page 
751
    751
  • Thumbnail: Page 
752
    752
  • Thumbnail: Page 
753
    753
  • Thumbnail: Page 
754
    754
  • Thumbnail: Page 
755
    755
  • Thumbnail: Page 
756
    756
  • Thumbnail: Page 
757
    757
  • Thumbnail: Page 
758
    758